Evaluation of Toll-Like Receptor 2 and 4 RNA Expression and the Cytokine Profile in Postmenopausal Women with Metabolic Syndrome

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2014 Oct 21

PMID 25329057

Citations 4

Authors

Claudio Lera Orsatti

Eliana Aguiar Petri Nahas

Jorge Nahas-Neto

Fabio Lera Orsatti

Vanessa Innocenti Giorgi

Steven S Witkin

Affiliations

Soon will be listed here.

Abstract

Objective: To evaluate the gene expression of Toll-Like (TLR-2 and TLR-4) receptors and cytokine profile in postmenopausal women with or without metabolic syndrome (MetS).

Methods: In this cross-sectional study, 311 Brazilian women (age≥45 years and amenorrhea≥12 months) were included. Women showing three or more of the following diagnostic criteria were diagnosed as positive for MetS: waist circumference>88 cm, triglycerides≥150 mg/dL, HDL cholesterol<50 mg/dL, blood pressure≥130/85 mmHg, and fasting glucose≥100 mg/dL. The expression of TLR-2 and TLR-4 in peripheral blood was evaluated by RNA extraction and subsequent real time PCR analysis. The cytokine profile, tumor necrosis factor alpha (TNF-α) and interleukins 1β, 6, and 10, were measured by ELISA.

Results: The expression of TLR-2 RNA was demonstrated in 32.5% and TLR-4 in 20.6% of the subjects. There was no association between the expression of TLR-2 and TLR-4 and the presence or absence of MetS (P>0.05). A greater production of IL-6 was associated with TLR-2 and TLR-4 expressions and greater production of TNF-α was associated only with TLR-2 expression (P>0.05). Only the lower quartile of IL-10 was associated with the presence of the MetS (P>0.05).

Conclusions: TLR-2 and TLR-4 expressions were associated with increased pro-inflammatory cytokines, IL-6 and TNF-α, with no association with biomarkers of MetS. The low concentrations of IL-10 may suggest an anti-inflammatory modulation in postmenopausal women with MetS.

Citing Articles

Associations of Osteoarthritis with Prevalence and Incidence of Cardiovascular Disease over 10 Years in Community-Dwelling Older Adults: The Sydney Memory and Ageing Study.

Zeng M, Cicuttini F, Lim Y, Samaras K, Brodaty H, Sachdev P Gerontology. 2024; 70(4):351-360.

PMID: 38330922 PMC: 11006274. DOI: 10.1159/000537721.

Can biomarkers be used to improve diagnosis and prediction of metabolic syndrome in childhood cancer survivors? A systematic review.

Pluimakers V, van Santen S, Fiocco M, Bakker M, van der Lelij A, van den Heuvel-Eibrink M Obes Rev. 2021; 22(11):e13312.

PMID: 34258851 PMC: 8596408. DOI: 10.1111/obr.13312.

Impact of Sex Differences and Diabetes on Coronary Atherosclerosis and Ischemic Heart Disease.

Madonna R, Balistreri C, De Rosa S, Muscoli S, Selvaggio S, Selvaggio G J Clin Med. 2019; 8(1).

PMID: 30654523 PMC: 6351940. DOI: 10.3390/jcm8010098.

Alterations in postmenopausal plasmatic lipidome.

Nogueira I, da Cruz E, Fontenele A, de Figueiredo Neto J PLoS One. 2018; 13(9):e0203027.

PMID: 30180197 PMC: 6122933. DOI: 10.1371/journal.pone.0203027.

References

Chedraui P, Jaramillo W, Perez-Lopez F, Escobar G, Morocho N, Hidalgo L . Pro-inflammatory cytokine levels in postmenopausal women with the metabolic syndrome. Gynecol Endocrinol. 2010; 27(9):685-91. DOI: 10.3109/09513590.2010.521270. View

Koch W, Hoppmann P, Pfeufer A, Schomig A, Kastrati A . Toll-like receptor 4 gene polymorphisms and myocardial infarction: no association in a Caucasian population. Eur Heart J. 2006; 27(21):2524-9. DOI: 10.1093/eurheartj/ehl231. View

Yasui T, Maegawa M, Tomita J, Miyatani Y, Yamada M, Uemura H . Changes in serum cytokine concentrations during the menopausal transition. Maturitas. 2006; 56(4):396-403. DOI: 10.1016/j.maturitas.2006.11.002. View

Poulain-Godefroy O, le Bacquer O, Plancq P, Lecoeur C, Pattou F, Fruhbeck G . Inflammatory role of Toll-like receptors in human and murine adipose tissue. Mediators Inflamm. 2010; 2010:823486. PMC: 2843862. DOI: 10.1155/2010/823486. View

Tsukumo D, Carvalho-Filho M, Carvalheira J, Prada P, Hirabara S, Schenka A . Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance. Diabetes. 2007; 56(8):1986-98. DOI: 10.2337/db06-1595. View

Garber C, Blissmer B, Deschenes M, Franklin B, LaMonte M, Lee I . American College of Sports Medicine position stand. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise. Med Sci Sports Exerc. 2011; 43(7):1334-59. DOI: 10.1249/MSS.0b013e318213fefb. View

Sutmuller R, Morgan M, Netea M, Grauer O, Adema G . Toll-like receptors on regulatory T cells: expanding immune regulation. Trends Immunol. 2006; 27(8):387-93. DOI: 10.1016/j.it.2006.06.005. View

Jialal I, Huet B, Kaur H, Chien A, Devaraj S . Increased toll-like receptor activity in patients with metabolic syndrome. Diabetes Care. 2012; 35(4):900-4. PMC: 3308307. DOI: 10.2337/dc11-2375. View

Cioffi M, Esposito K, Vietri M, Gazzerro P, DAuria A, Ardovino I . Cytokine pattern in postmenopause. Maturitas. 2002; 41(3):187-92. DOI: 10.1016/s0378-5122(01)00286-9. View

10.

Cole J, Georgiou E, Monaco C . The expression and functions of toll-like receptors in atherosclerosis. Mediators Inflamm. 2010; 2010:393946. PMC: 2905957. DOI: 10.1155/2010/393946. View

11.

Perez Fernandez R, Kaski J . [Interleukin-10 and coronary disease]. Rev Esp Cardiol. 2002; 55(7):738-50. DOI: 10.1016/s0300-8932(02)76693-1. View

12.

Smith D, IRVING S, Sheldon J, Cole D, Kaski J . Serum levels of the antiinflammatory cytokine interleukin-10 are decreased in patients with unstable angina. Circulation. 2001; 104(7):746-9. DOI: 10.1161/hc3201.094973. View

13.

Lepper P, Triantafilou M, ONeill L, Novak N, Wagner H, Parker A . Modulation of toll-like receptor signalling as a new therapeutic principle. Mediators Inflamm. 2011; 2010:705612. PMC: 3022219. DOI: 10.1155/2010/705612. View

14.

Methe H, Kim J, Kofler S, Weis M, Nabauer M, Koglin J . Expansion of circulating Toll-like receptor 4-positive monocytes in patients with acute coronary syndrome. Circulation. 2005; 111(20):2654-61. DOI: 10.1161/CIRCULATIONAHA.104.498865. View

15.

Krikun G, Trezza J, Shaw J, Rahman M, Guller S, Abrahams V . Lipopolysaccharide appears to activate human endometrial endothelial cells through TLR-4-dependent and TLR-4-independent mechanisms. Am J Reprod Immunol. 2012; 68(3):233-7. PMC: 3418410. DOI: 10.1111/j.1600-0897.2012.01164.x. View

16.

Ferrario C, Strawn W . Role of the renin-angiotensin-aldosterone system and proinflammatory mediators in cardiovascular disease. Am J Cardiol. 2006; 98(1):121-8. DOI: 10.1016/j.amjcard.2006.01.059. View

17.

Grundy S, Brewer Jr H, Cleeman J, Smith Jr S, Lenfant C . Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Arterioscler Thromb Vasc Biol. 2004; 24(2):e13-8. DOI: 10.1161/01.ATV.0000111245.75752.C6. View

18.

Hamann L, Gomma A, Schroder N, Stamme C, Glaeser C, Schulz S . A frequent toll-like receptor (TLR)-2 polymorphism is a risk factor for coronary restenosis. J Mol Med (Berl). 2005; 83(6):478-85. DOI: 10.1007/s00109-005-0643-7. View

19.

Wildman R, Muntner P, Reynolds K, McGinn A, Rajpathak S, Wylie-Rosett J . The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med. 2008; 168(15):1617-24. DOI: 10.1001/archinte.168.15.1617. View

20.

Akira S, Takeda K, Kaisho T . Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol. 2001; 2(8):675-80. DOI: 10.1038/90609. View